Advertisement

Supportive Care in Cancer

, Volume 19, Issue 4, pp 555–564 | Cite as

Effect of virtual reality on time perception in patients receiving chemotherapy

  • Susan M. SchneiderEmail author
  • Cassandra K. Kisby
  • Elizabeth P. Flint
Original Article

Abstract

Purpose

Virtual reality (VR) during chemotherapy has resulted in an elapsed time compression effect, validating the attention diversion capabilities of VR. Using the framework of the pacemaker–accumulator cognitive model of time perception, this study explored the influence of age, gender, state anxiety, fatigue, and cancer diagnosis in predicting the difference between actual time elapsed during receipt of intravenous chemotherapy while immersed in a VR environment versus patient’s retrospective estimates of time elapsed during this treatment.

Materials and methods

This secondary analysis from three studies yielded a pooled sample of N = 137 participants with breast, lung, or colon cancer. Each study employed a crossover design requiring two matched intravenous chemotherapy treatments, with participants randomly assigned to receive VR during one treatment. Regressions modeled the effect of demographic variables, diagnosis, and Piper Fatigue Scale and State Anxiety Inventory scores on the difference between actual and estimated time elapsed during chemotherapy with VR.

Results

In a forward regression model, three predictors (diagnosis, gender, and anxiety) explained a significant portion of the variability for altered time perception (F=5.06, p = 0.0008). Diagnosis was the strongest predictor; individuals with breast and colon cancer perceived time passed more quickly.

Conclusions

VR is a noninvasive intervention that can make chemotherapy treatments more tolerable. Women with breast cancer are more likely and lung cancer patients less likely to experience altered time perception during VR (a possible indicator of effectiveness for this distraction intervention). Understanding factors that predict responses to interventions can help clinicians tailor coping strategies to meet each patient’s needs.

Keywords

Virtual reality Time perception Distraction Chemotherapy Cancer 

Notes

Acknowledgments

Data used in these analyses were from studies funded by the American Cancer Society, the Oncology Nursing Foundation (through an unrestricted grant from Ortho Biotech Products, L.P.), NINR 1 P20 NR07795-01 (PI: E. Clipp), and Duke University Medical Center.

Author disclosures

The authors of this manuscript have no conflicts of interest to disclose. The authors have no financial relationship with the organizations that sponsored the research. The corresponding/primary author has full control of all the primary data and agrees to allow the journal to review the data if requested.

References

  1. 1.
    Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D, Copley-Merriman K, Hsu M-A (2005) Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health 8(Suppl 1):S41–S53. doi: 10.1111/j.1524-4733.2005.00073.x PubMedCrossRefGoogle Scholar
  2. 2.
    Bell K (2009) ‘If it almost kills you that means it’s working!’ Cultural models of chemotherapy expressed in a cancer support group. Soc Sci Med 68(1):169–176. doi: 10.1016/j.socscimed.2008.10.023 PubMedCrossRefGoogle Scholar
  3. 3.
    Brañas-Garza P, Espinosa-Fernández L, Serrano-del-Rosal R (2007) Effects of gender and age on retrospective time judgements. Time Soc 16(1):99–118. doi: 10.1177/0961463x07074104 CrossRefGoogle Scholar
  4. 4.
    Buhusi CV, Meck WH (2005) What makes us tick? Functional and neural mechanisms of interval timing. Nat Rev Neurosci 6(10):755–765. doi: 10.1038/nrn1764 PubMedCrossRefGoogle Scholar
  5. 5.
    Burle B, Casini L (2001) Dissociation between activation and attention effects in time estimation: implications for internal clock models. J Exp Psychol Hum Percept Perform 27(1):195–205. doi: 10.1037/0096-1523.27.1.195 PubMedCrossRefGoogle Scholar
  6. 6.
    Chaston A, Kingstone A (2004) Time estimation: the effect of cortically mediated attention. Brain Cogn 55(2):286–289. doi: 10.1016/j.bandc.2004.02.013 PubMedCrossRefGoogle Scholar
  7. 7.
    Chernecky C (1999) Temporal differences in coping, mood, and stress with chemotherapy. Cancer Nurs 22(4):266–276PubMedCrossRefGoogle Scholar
  8. 8.
    Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497–503. doi: 10.1007/s00520-006-0173-z PubMedCrossRefGoogle Scholar
  9. 9.
    Cox AC, Fallowfield LJ (2007) After going through chemotherapy I can’t see another needle. Eur J Oncol Nurs 11(1):43–48. doi: 10.1016/j.ejon.2006.04.035 PubMedCrossRefGoogle Scholar
  10. 10.
    Dahlquist LM, Weiss KE, Clendaniel LD, Law EF, Ackerman CS, McKenna KD (2009) Effects of videogame distraction using a virtual reality type head-mounted display helmet on cold pressor pain in children. J Pediatr Psychol 34(5):574–584. doi: 10.1093/jpepsy/jsn023 PubMedCrossRefGoogle Scholar
  11. 11.
    DeVita VT Jr, Chu E (2008) A history of cancer chemotherapy. Cancer Res 68(21):8643–8653. doi: 10.1158/0008-5472.CAN-07-6611 PubMedCrossRefGoogle Scholar
  12. 12.
    Droit-Volet S, Gil S (2009) The time–emotion paradox. Philos Trans R Soc Lond B Biol Sci 364(1525):1943–1953. doi: 10.1098/rstb.2009.0013 PubMedCrossRefGoogle Scholar
  13. 13.
    Fischer DJ, Villines D, Kim YO, Epstein JB, Wilkie DJ (2010) Anxiety, depression, and pain: differences by primary cancer. Support Care Cancer. doi: 10.1007/s00520-009-0712-5
  14. 14.
    Gershon J, Zimand E, Pickering M, Rothbaum BO, Hodges L (2004) A pilot and feasibility study of virtual reality as a distraction for children with cancer. J Am Acad Child Adolesc Psychiatr 43(10):1243–1249. doi: 10.1097/01.chi.0000135621.23145.05 CrossRefGoogle Scholar
  15. 15.
    Goldspiel BR (2004) Chemotherapy dose density in early-stage breast cancer and non-Hodgkin’s lymphoma. Pharmacotherapy 24(10):1347–1357. doi: 10.1592/phco.24.14.1347.43154 PubMedCrossRefGoogle Scholar
  16. 16.
    Greer JA, Pirl WF, Park ER, Lynch TJ, Temel JS (2008) Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 65(6):549–552. doi: 10.1016/j.jpsychores.2008.03.005 PubMedCrossRefGoogle Scholar
  17. 17.
    Grondin S, Plourde M (2007) Judging multi-minute intervals retrospectively. Q J Exp Psychol 60(9):1303–1312. doi: 10.1080/17470210600988976 CrossRefGoogle Scholar
  18. 18.
    Hoffman HG, Richards TL, Bills AR, Van Oostrom T, Magula J, Seibel EJ, Sharar SR (2006) Using FMRI to study the neural correlates of virtual reality analgesia. CNS Spectr 11(1):45–51PubMedGoogle Scholar
  19. 19.
    Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR (2004) Cancer patients’ expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center-community clinical oncology program study of 938 patients from community practices. Cancer 101(4):851–857. doi: 10.1002/cncr.20423 PubMedCrossRefGoogle Scholar
  20. 20.
    Humphreys GR, Buehner MJ (2009) Magnitude estimation reveals temporal binding at super-second intervals. J Exp Psychol Hum Percept Perform 35(5):1542–1549. doi: 10.1037/a0014492 PubMedCrossRefGoogle Scholar
  21. 21.
    Kwekkeboom KL (2003) Music versus distraction for procedural pain and anxiety in patients with cancer. Oncol Nurs Forum 30(3):433–440. doi: 10.1188/03.ONF.433-440 PubMedCrossRefGoogle Scholar
  22. 22.
    Magora F, Cohen S, Shochina M, Dayan E (2006) Virtual reality immersion method of distraction to control experimental ischemic pain. Isr Med Assoc J 8(4):261–265PubMedGoogle Scholar
  23. 23.
    Mahrer NE, Gold JI (2009) The use of virtual reality for pain control: a review. Curr Pain Headache Rep 13(2):100–109. doi: 10.1007/s11916-009-0019-8 PubMedCrossRefGoogle Scholar
  24. 24.
    McIlfatrick S, Sullivan K, McKenna H, Parahoo K (2007) Patients’ experiences of having chemotherapy in a day hospital setting. J Adv Nurs 59(3):264–273. doi: 10.1111/j.1365-2648.2007.04324.x PubMedCrossRefGoogle Scholar
  25. 25.
    Miró E, Cano MC, Espinosa-Fernández L, Buela-Casal G (2003) Time estimation during prolonged sleep deprivation and its relation to activation measures. Hum Factors 45(1):148–159. doi: 10.1518/hfes.45.1.148.27227 PubMedCrossRefGoogle Scholar
  26. 26.
    Molassiotis A, Saunders MP, Valle J, Wilson G, Lorigan P, Wardley A, Levine E, Cowan R, Loncaster J, Rittenberg C (2008) A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Support Care Cancer 16(2):201–208. doi: 10.1007/s00520-007-0343-7 PubMedCrossRefGoogle Scholar
  27. 27.
    Morris LD, Louw QA, Grimmer-Somers K (2009) The effectiveness of virtual reality on reducing pain and anxiety in burn injury patients: a systematic review. Clin J Pain 25(9):815–826. doi: 10.1097/AJP.0b013e3181aaa909 PubMedCrossRefGoogle Scholar
  28. 28.
    Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised piper fatigue scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMedGoogle Scholar
  29. 29.
    Roscoe JA, Morrow GR, Colagiuri B, Heckler CE, Pudlo BD, Colman L, Hoelzer K, Jacobs A (2010) Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer. doi: 10.1007/s00520-009-0723-2
  30. 30.
    Schneider SM (2007) A series of studies exploring the use of virtual reality for chemotherapy treatments. Oncol Nurs Forum 34(1):182–183. doi: 10.1188/07.ONF.39-46 CrossRefGoogle Scholar
  31. 31.
    Schneider SM, Ellis M, Coombs WT, Shonkwiler EL, Folsom LC (2003) Virtual reality intervention for older women with breast cancer. Cyberpsychol Behav 6(3):301–307. doi: 10.1089/109493103322011605 PubMedCrossRefGoogle Scholar
  32. 32.
    Schneider SM, Hood LE (2007) Virtual reality: a distraction intervention for chemotherapy. Oncol Nurs Forum 34(1):39–46. doi: 10.1188/07.ONF.39-46 PubMedCrossRefGoogle Scholar
  33. 33.
    Schneider SM, Prince-Paul M, Allen MJ, Silverman P, Talaba D (2004) Virtual reality as a distraction intervention for women receiving chemotherapy. Oncol Nurs Forum 31(1):81–88. doi: 10.1188/04.ONF.81-88 PubMedCrossRefGoogle Scholar
  34. 34.
    Schneider SM, Workman ML (2000) Virtual reality as a distraction intervention for older children receiving chemotherapy. Pediatr Nurs 26(6):593–597PubMedGoogle Scholar
  35. 35.
    Sharar SR, Miller W, Teeley A, Soltani M, Hoffman HG, Jensen MP, Patterson DR (2008) Applications of virtual reality for pain management in burn-injured patients. Expert Rev Neurother 8(11):1667–1674. doi: 10.1586/14737175.8.11.1667 PubMedCrossRefGoogle Scholar
  36. 36.
    Somov PG (2000) Time perception as a measure of pain intensity and pain type. J Back Musculoskelet Rehabil 14(3):111–121Google Scholar
  37. 37.
    Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Palo AltoGoogle Scholar
  38. 38.
    Thuné-Boyle ICV, Myers LB, Newman SP (2006) The role of illness beliefs, treatment beliefs, and perceived severity of symptoms in explaining distress in cancer patients during chemotherapy treatment. Behav Med 32(1):19–29. doi: 10.3200/BMED.32.1.19-29 PubMedCrossRefGoogle Scholar
  39. 39.
    Tobin S, Grondin S (2009) Video games and the perception of very long durations by adolescents. Comput Hum Behav 25(2):554–559. doi: 10.1016/j.chb.2008.12.002 CrossRefGoogle Scholar
  40. 40.
    Verdura GS, Alaimo S, Borzì R, Fazio M, Scavo V (2005) Trying to listen: needs of patients treated with chemotherapy. Support Palliat Cancer Care 2(1):15–20Google Scholar
  41. 41.
    Wearden JH (2008) The perception of time: basic research and some potential links to the study of language. Lang Learn 58:149–171. doi: 10.1111/j.1467-9922.2008.00468.x CrossRefGoogle Scholar
  42. 42.
    Wiederhold MD, Wiederhold BK (2007) Virtual reality and interactive simulation for pain distraction. Pain Med 8(Suppl 3):S182–S188. doi: 10.1111/j.1526-4637.2007.00381.x CrossRefGoogle Scholar
  43. 43.
    Wittmann M, Paulus MP (2008) Decision making, impulsivity and time perception. Trends Cogn Sci 12(1):7–12. doi: 10.1016/j.tics.2007.10.004 PubMedCrossRefGoogle Scholar
  44. 44.
    Wittmann M, Vollmer T, Schweiger C, Hiddemann W (2006) The relation between the experience of time and psychological distress in patients with hematological malignancies. Palliat Support Care 4(4):357–363. doi: 10.1017/S1478951506060469 PubMedCrossRefGoogle Scholar
  45. 45.
    Yoo HJ, Ahn SH, Kim SB, Kim WK, Han OS (2005) Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life. Support Care Cancer 13(10):826–833. doi: 10.1007/s00520-005-0806-7 PubMedCrossRefGoogle Scholar
  46. 46.
    Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H (2007) Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity. Ann Behav Med 33(1):69–79. doi: 10.1207/s15324796abm3301_8 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Susan M. Schneider
    • 1
    Email author
  • Cassandra K. Kisby
    • 2
  • Elizabeth P. Flint
    • 1
  1. 1.Duke University School of NursingDurhamUSA
  2. 2.Duke University School of MedicineDurhamUSA

Personalised recommendations